Western Standard LLC Keros Therapeutics, Inc. Transaction History
Western Standard LLC
- $180 Million
- Q2 2025
A detailed history of Western Standard LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Western Standard LLC holds 1,534,893 shares of KROS stock, worth $21 Million. This represents 11.4% of its overall portfolio holdings.
Number of Shares
1,534,893
Previous 134,914
1037.68%
Holding current value
$21 Million
Previous $1.37 Million
1391.27%
% of portfolio
11.4%
Previous 0.82%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
155Shares Held
38.6MCall Options Held
834KPut Options Held
969K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$73.9 Million11.03% of portfolio
-
Madison Avenue Partners, LP New York, NY2.69MShares$36.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $353M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...